arrow
M

Marwa Alsulaimany

taibah university
H指数:9
被引数:186

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ADMET, docking, anticancer evaluations, design and synthesis of pyrazolo[1,5-a]pyrimidines substituted with furan and phenyldiazene as dual EGFRT790M and VEGFR-2 inhibitors

ADMET、对接、抗癌评估、含呋喃和苯基叠氮的吡唑并[1,5-a]嘧啶的设计与合成,作为EGFR-T790M和VEGFR-2双重抑制剂

2025-07-140
PRE
Hirsutolide isolated from Arctotis fastuosa induces apoptosis and inhibits viability, migration, and invasion of MCF-7 breast cancer cell

从Arctotis fastuosa中分离得到的Hirsutolide能够诱导MCF-7乳腺癌细胞凋亡,并抑制其活力、迁移和侵袭能力。

2025-06-010
OAAI
Nano-carrier, design, synthesis, in silico ADMET, anti-proliferative assessments and docking of [1,2,4]triazolo[4,3-a]quinoxalines as Topo-II inhibitors and DNA intercalators

纳米载体、设计、合成、计算机辅助ADMET、抗增殖评估和对接研究:作为Topo-II抑制剂的[1,2,4]三唑并[4,3-a]喹喔啉类化合物及其DNA嵌入剂

2025-04-110
PRE
Design, synthesis and biological evaluation of pyrazolo[3,4-b]pyridine derivatives as dual CDK2/PIM1 inhibitors with potent anti-cancer activity and selectivity

吡唑并[3,4-b]吡啶衍生物的设计、合成及其作为具有强效抗肿瘤活性和选择性的CDK2/PIM1双靶点抑制剂的生物活性评价

2025-03-130
PRE
Design, nanogel synthesis, anti-proliferative activity and in silico ADMET profile of pyrazoles and pyrimidines as topo-II inhibitors and DNA intercalators

设计、纳米凝胶合成、抗增殖活性及吡唑和嘧啶作为拓扑异构酶-II抑制剂和DNA嵌入剂的在计算机ADMET特性

2025-01-010
OA